Medical Oncologist
BC Cancer Victoria, Canada
I completed Oncology training in Israel in 2017. During the last 3 years, I continued specialty training and participated in the Toronto Sarcoma Program Fellowship at Princess Margaret Cancer Centre and Mount Sinai Hospital. My work was mainly focused on translational research and new anticancer drug development in sarcoma tumors. I have significant experience in the clinical management of patients with sarcoma and skin cancer. For the last three years, I have been taking part in the Leiomyosarcoma (LMS) project, led by Gladdy Lab and the Toronto Sarcoma group. My current work focuses on the development of promising drug combinations, based on genomic analysis, performed in terms of the first part of the LMS project.
Implication of clinical experience into planning and analysis of preclinical data allows focusing on drug combinations with high potential for clinical trial development. Our final goal is to improve the outcomes of patients with advanced LMS, by developing more efficient treatment, based on deep genomic analysis and a better understanding of tumor biology. In terms of clinical experience currently, I am a co-investigator in more than 15 active clinical trials at the Princess Margaret Cancer Centre, encompassing early phase trials as well as sarcoma studies, involving molecularly targeted and immunotherapeutic strategies as well as part of the molecular profiling endeavors at my institutions. To date, I have published 15 peer-reviewed manuscripts, authored one book chapter, and published 24 abstracts. I am the recipient of the ASCO Conquer Cancer Merit Award.
